cancer-associated fibroblasts

You have access
Preclinical Evaluation of ⁶⁸Ga/¹⁷⁷Lu-Labeled FAP-Targeted Peptide for Tumor Radiopharmaceutical Imaging and Therapy
Rang Wang, Mingxing Huang, Weichen Wang, Mufeng Li, Yingwei Wang and Rong Tian

Journal of Nuclear Medicine February 1, 2025, 66 (2) 250-256; DOI: https://doi.org/10.2967/jnumed.124.268689
Open Access
Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy
Yizhen Pang, Liang Zhao, Jianyang Fang, Jianhao Chen, Lingxin Meng, Long Sun, Hua Wu, Zhide Guo, Qin Lin and Haojun Chen

Journal of Nuclear Medicine September 1, 2023, 64 (9) 1449-1455; DOI: https://doi.org/10.2967/jnumed.123.265599
You have access
Fibroblast Activation Protein Inhibitor–Based Radionuclide Therapies: Current Status and Future Directions
Manish Ora, Neetu Soni, Aftab Hasan Nazar, Manish Dixit, Rohit Singh, Savita Puri, Michael M. Graham and Sanjay Gambhir

Journal of Nuclear Medicine July 1, 2023, 64 (7) 1001-1008; DOI: https://doi.org/10.2967/jnumed.123.265594
You have access
Fibroblast Activation Protein–Targeted Radioligand Therapy for Treatment of Solid Tumors
Spencer D. Lindeman, Ramesh Mukkamala, Autumn Horner, Pooja Tudi, Owen C. Booth, Roxanne Huff, Joshua Hinsey, Anders Hovstadius, Peter Martone, Fenghua Zhang, Madduri Srinivasarao, Abigail Cox and Philip S. Low

Journal of Nuclear Medicine May 1, 2023, 64 (5) 759-766; DOI: https://doi.org/10.2967/jnumed.122.264494
Open Access
Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of ⁶⁸Ga-Labeled FAPI Dimer
Liang Zhao, Bo Niu, Jianyang Fang, Yizhen Pang, Siyang Li, Chengrong Xie, Long Sun, Xianzhong Zhang, Zhide Guo, Qin Lin and Haojun Chen

Journal of Nuclear Medicine June 1, 2022, 63 (6) 862-868; DOI: https://doi.org/10.2967/jnumed.121.263016
You have access
Detecting Fibroblast Activation Proteins in Lymphoma Using ⁶⁸Ga-FAPI PET/CT
Xiao Jin, Maomao Wei, Shuailiang Wang, Guochang Wang, Yumei Lai, Yunfei Shi, Yan Zhang, Zhi Yang and Xuejuan Wang

Journal of Nuclear Medicine February 1, 2022, 63 (2) 212-217; DOI: https://doi.org/10.2967/jnumed.121.262134
Open Access
FAPI-74 PET/CT Using Either ¹⁸F-AlF or Cold-Kit ⁶⁸Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients
Frederik L. Giesel, Sebastian Adeberg, Mustafa Syed, Thomas Lindner, Luis David Jiménez-Franco, Eleni Mavriopoulou, Fabian Staudinger, Eric Tonndorf-Martini, Sebastian Regnery, Stefan Rieken, Rami El Shafie, Manuel Röhrich, Paul Flechsig, Andreas Kluge, Annette Altmann, Jürgen Debus, Uwe Haberkorn and Clemens Kratochwil

Journal of Nuclear Medicine February 1, 2021, 62 (2) 201-207; DOI: https://doi.org/10.2967/jnumed.120.245084
You have access
Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an ¹⁸F-Labeled FAP Inhibitor
Johannes Toms, Jürgen Kogler, Simone Maschauer, Christoph Daniel, Christian Schmidkonz, Torsten Kuwert and Olaf Prante

Journal of Nuclear Medicine December 1, 2020, 61 (12) 1806-1813; DOI: https://doi.org/10.2967/jnumed.120.242958
Open Access
⁶⁸Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers
Frederik L. Giesel, Clemens Kratochwil, Thomas Lindner, Manfred M. Marschalek, Anastasia Loktev, Wencke Lehnert, Jürgen Debus, Dirk Jäger, Paul Flechsig, Annette Altmann, Walter Mier and Uwe Haberkorn

Journal of Nuclear Medicine March 1, 2019, 60 (3) 386-392; DOI: https://doi.org/10.2967/jnumed.118.215913

Main menu

User menu

Search

cancer-associated fibroblasts